Double-Blind, Randomized, Phase 2a Study to Evaluate the Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix Tetra(®) or Afluria Quad(®).
Overview & Synopsis
Open access biomedical research article published in Vaccines (Basel).
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Double-Blind, Randomized, Phase 2a Study to Evaluate the Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix Tetra(®) or Afluria Quad(®). |
|---|---|
| Author / Organization | Groth N, Bruhwyler J, Piat E, Tourneur J, Moris P, Penlington M, Nicolas F, Le Vert A |
| Subject & Discipline | Vaccines (Basel) |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-125763 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |